Ajanta Pharma Launches Met XL AMT 25 mg a triple FDC for Uncontrolled Hypertension with CAD Deeksha Bhandari20 Jun 2025 12:00 PM ISTIn a first move Ajanta pharma one of the leaders in the cardiology segment, has announced the launch of Met XL AMT 25 mg. It is a triple-drug...
LVAD good for heart failure but may increase Stroke Risk, reveals research Dr. Kamal Kant Kohli16 Jun 2025 9:00 PM ISTResearchers have found in a new study that people with Left Ventricular Assist Devices (LVADs) have an 11% to 47% higher risk of developing blood...
Genetic Link Found Between Early-Onset AF and Risk of Cardiomyopathy or Heart Failure: Study Dr. Shravani Dali15 Jun 2025 9:30 PM ISTResearchers have found in a cohort study that there is a significant prevalence of CMP-PLP genetic variants in patients with early-onset atrial...
Medical Bulletin 4/June/2025 Dr. Bhumika Maikhuri4 Jun 2025 2:40 PM ISTHere are the top medical news for the day:How Your Morning Coffee Could Boost Brain and Body Health? A recent study presented at NUTRITION 2025, the...
Study Shows Combination Therapy May Improve Survival in Severe Heart Disease Dr. Bhumika Maikhuri4 Jun 2025 8:30 AM ISTA new study has demonstrated that combining aortic valve replacement with targeted drug therapy significantly improves survival in patients suffering...
Less Social Isolation Linked to Better Self-Care in Heart Failure Patients: Study Meghna A Singhania2 Jun 2025 4:41 PM ISTPatients with heart failure (HF) who are less socially isolated demonstrate significantly better self-care behaviors, according to a new study, while...
Largest phase 3 trial of novel treatment for hypertension shows promising results Dr. Kamal Kant Kohli28 May 2025 8:30 PM ISTThe data from the Launch-HTN trial, announced at the 34th European Meeting on Hypertension and Cardiovascular Protection, show that lorundrostat, an...
Senores Pharma boosts heart health portfolio with acquisition of USFDA approved Enalapril Tablets ANDA from Wockhardt Ruchika Sharma23 May 2025 11:00 AM ISTAhmedabad: Senores Pharmaceuticals Limited (SPL), through its wholly-owned subsidiary Senores Pharmaceuticals, Inc., USA (SPI), has signed ...
Ajanta Pharma Launches Met-XL D to Improve Outcomes for Heart Failure and Post-Myocardial Infarction Patients Deeksha Bhandari22 May 2025 12:30 PM ISTAjanta Pharma, one of the leaders in the cardiology segment has launched the fixed dose combination of Metoprolol and Dapagliflozin under the brand...
Sacubitril/Valsartan may Improve Diabetic Cardiomyopathy via Immunomodulation of Inflammation: Study Dr. Shravani Dali22 May 2025 8:45 AM ISTA recent study published in Cardiovascular Diabetology reveals that Sacubitril/Valsartan, a combination of a neprilysin inhibitor and an angiotensin...
USFDA Flags Sarfez Pharma for Misleading Promotion of Torsemide Drug Soaanz Farhat Nasim20 May 2025 8:24 PM ISTUS: In a stern regulatory move, the United States Food and Drug Administration (USFDA) has issued a warning letter to Virginia-based Sarfez...
Waist-to-height ratio may predict heart failure incidence, suggests research Dr. Kamal Kant Kohli20 May 2025 7:30 AM ISTWaist-to-height ratio predicts heart failure incidence, according to research presented today at Heart Failure 2025, a scientific congress of the...
